A 2026 change to India's transgender recognition law has thrown gender-affirming care into chaos, with clinics pausing hormone therapy and surgeries going on indefinite hold. The law scrapped self-identification, replacing it with certification by a medical panel — but the government hasn't defined who qualifies for those panels. Doctors are confused, patients are stranded, and activists warn the restrictions could push people toward unregulated, unsafe care.
India's 2026 amendment to its transgender recognition law has sent shockwaves through the country's gender-affirming care system. The change eliminated self-identification as a basis for legal gender recognition, replacing it with certification from a government-appointed medical panel. But with the composition and authority of those panels still undefined, providers are paralyzed — pausing hormone replacement therapy (HRT), delaying surgeries, and asking patients to sign voluntary consent declarations to protect themselves legally.
The fallout is immediate and medically significant. At least a dozen transgender individuals told Reuters their care had been disrupted, with some traveling long distances to find willing providers and others relying on outdated prescriptions. Abruptly stopping HRT can cause bone density loss and menopause-like symptoms, making the disruption a serious medical concern — not just a bureaucratic inconvenience.
Key Takeaways:
Why it matters: India's policy shift mirrors a global trend of tightening restrictions on gender-affirming care. For healthcare providers, the legal ambiguity creates a chilling effect that directly harms patient health — and the lack of regulatory clarity shows how quickly policy gaps can translate into a public health crisis.
